Partners
Cooperating partners
Cooperating conferences
Extracellular Vesicles Asia 2026: Technologies to Dx and Rx

SelectBIO Extracellular Vesicles Asia 2026: Technologies to Dx and Rx is being held December 3-4, 2026 at the ibis Kuala Lumpur City Centre - Kuala Lumpur, Malaysia.
SelectBIO is honored to welcome Professor Hsueh-Chia Chang, Bayer Professor of Chemical and Biomolecular Engineering, University of Notre Dame; Co-Founder & CTO, Aopia Biosciences, as the Conference Chairperson. This conference brings together academics and industry participants from across Asia/Pacific plus US and Europe to present and discuss the most up-to-date research trends in Extracellular Vesicles (EVs, Exosomes) with a strong emphasis on the translational aspects, namely:
- 1. Technology and Tools Development
- 2. Work Towards Diagnostics Development
- 3. Drug Delivery and Therapeutics Development
The conference strongly welcomes companies to describe their technologies and platforms for life science researchers as well as drug discovery-and-development applications.
Third International StemNet Meeting

International StemNet Meeting will take place in Bologna (Italy) on March 12-13, 2026. StemNet is a federation of the four main associations of stem cell research in Italy (FIRST, GISM, IPLASS, SCRI) that share and synergize experiences to enhance both the quality and the impact of research in this advancing field. This meeting marks the constructive relationship among our associations and aims to improve the exchange of relevant and up-to-date information in the field of advanced cell therapy. The six sessions of the meeting will spotlight relevant progress in basic and translational research. The meeting also includes discussions on critical aspects of biomedical communication and research valorization and will include a “next generation session” organized by young scientists. A faculty of national and international experts and renowned speakers will foster exciting and inspiring debates of the challenging scientific program.
D-A-CH EV Meeting 2026

The program will feature sessions on the fundamentals of EV biology, purification and characterization, methodological advances, microbial EVs, clinical translation, reproducibility and open questions in EV research, as well as novel EV sources and emerging concepts. Keynotes, selected abstracts, poster sessions, roundtable discussions, and industry presentations will offer a broad and interactive scientific agenda. A welcome reception and social event will further create space for networking and exchange.
8th International GEIVEX Symposium
GEIVEX is a consolidated non-profit organization aiming to advance personalized medicine by developing new tools and biomarkers with high social impact to generate benefits and equality in global health.
We believe that the combination of basic and clinical research, as in many other fields, is the basis for translational extracellular vesicle (EV) studies that will lead to future approaches to disease. To achieve productive discussions and maintain the excellent standards of our symposium, we are already working on providing a broad scope of sessions covering the latest technological advances, fundamental knowledge, and EV-based applications, with high-quality keynote speakers for each session.
Based on the previous success experiences of the GEIVEX symposium in Santiago de Compostela (2022) and Palma de Mallorca (2024), we are also planning an Educational Day workshop on the pre-meeting day (October 6th) under the theme “Practical sessions to explore new EV-focused technological advances”. We are aware that this type of activity is highly welcomed by EV researchers and is a great opportunity for companies to promote state-of-the-art technologies for EV analysis.
The 8th International GEIVEX Symposium in 2026 will be an important opportunity to create and strengthen partnerships among professionals dedicated to EV research, both basic and clinical, as well as to meet renowned speakers.
14th International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS)
From the clinical problem to the research model: a translational approach with EVs

German Society for Extracellular Vesicles (GSEV) - Autumn Meeting 2025

The meeting features a vibrant two-day program including keynote lectures by leading international experts, interactive round table discussions, industry sessions, and opportunities for early-career researchers to present their work as talks or posters. Topics span EV biogenesis, advanced characterization and standardization, novel functions and biomarkers, and translational applications in regenerative medicine, oncology, immunology, and neurology.
The event aims to promote scientific exchange, collaboration and community building in the field of EVs.
Asia Pacifc Societies for Extracellular Vesicles (ASPEV) Conference 2025

The Asia Pacific Societies for Extracellular Vesicles Conference 2025 (APSEV 2025) is a joint collaboration among extracellular vesicles (EV) societies from China’s mainland, Japan, Korea, Taiwan, Australia/New Zealand, India, and Malaysia, and will bring together a diverse group of experts, practitioners, researchers, and students to showcase the latest advancements, innovations, and discuss challenges in the rapidly evolving EV landscape. The conference will feature plenary, keynote and invited lectures, exhibitors, and selected scientific oral and poster presentations in 9 different EV sessions to offer a vibrant platform for networking, knowledge exchange, and collaboration across the Asia-Pacific region and beyond.
Previous conferences
7th GEIVEX Symposium
The 3rd International Symposium on Microgenomics 2023
Extracellular Vesicles: friends and foes II
30th Annual Molecular & Precision Med TRI-CON
2nd mRNA Analytical Development Summit
2nd Annual mRNA Based Therapeutics Summit European
Expect exclusive data from KOLs in mRNA vaccine and therapy development. Join 250+ pioneers from the likes of Moderna, Sanofi, BioNTech, Pantherna Therapeutics, and more as we explore the development of mRNA vaccines and therapies from research through to commercialisation and to patients in need.
4th Exosome Based Therapeutic Development Summit
Welcome to join 130+ biopharma experts from Codiak BioSciences, Rion, MDimmune, Aruna Bio and more to exchange your ideas and initiate collaborations to effectively improve extracellular vesicle-based and exosome therapeutics towards the first clinical approval.























